This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Endomedix, Inc.. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Innovations in Hemostasis: The Contributions of Malavika Nadig
Introduction
Malavika Nadig is an accomplished inventor based in Harrison, NJ (US). She has made significant contributions to the field of medical technology, particularly in the development of innovative solutions for achieving hemostasis. With a total of 3 patents to her name, her work is paving the way for advancements in surgical procedures.
Latest Patents
One of her latest patents focuses on methods and compositions for achieving hemostasis and stable blood clot formation. This invention involves a tunable biopolymer hydrogel produced from two processed natural polysaccharides. The hydrogel can be engineered to form within seconds when applied to a tissue lesion. It adheres to tissue without swelling, producing hemostasis almost immediately after application. Additionally, the hydrogel captures, aggregates, and concentrates platelets and red blood cells at the site of the lesion, initiating a clotting cascade. This hemostatic solution is particularly beneficial during surgical procedures, such as those involving the brain or spine, where swelling could pose risks to the patient.
Career Highlights
Malavika is currently associated with Endomedix, Inc., where she continues to innovate in the medical field. Her work is characterized by a commitment to improving patient outcomes through advanced technology.
Collaborations
She collaborates with talented professionals, including Piyush Modak and Richard Russo, to further enhance the impact of her inventions.
Conclusion
Malavika Nadig's contributions to the field of hemostasis exemplify the importance of innovation in medical technology. Her work not only addresses critical challenges in surgical procedures but also highlights the potential for biopolymer hydrogels in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
